BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 3160627)

  • 1. Molecular biology of type 1 (insulin-dependent) diabetes mellitus.
    Lernmark A
    Diabetologia; 1985 Apr; 28(4):195-203. PubMed ID: 3160627
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoimmunity in the genesis of beta-pancreatic lesions].
    Doniach D; Mirakian R; Dean B; Richardson A; Bottazzo GF
    Journ Annu Diabetol Hotel Dieu; 1984; ():151-62. PubMed ID: 6399531
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-cell damage in diabetic insulitis: are we approaching a solution?
    Bottazzo GF
    Diabetologia; 1984 Apr; 26(4):241-9. PubMed ID: 6376230
    [No Abstract]   [Full Text] [Related]  

  • 4. Selecting culprits in type 1 diabetes beta-cell killing.
    Lernmark A
    J Clin Invest; 1999 Dec; 104(11):1487-9. PubMed ID: 10587509
    [No Abstract]   [Full Text] [Related]  

  • 5. Islet cell antibodies and cellular immunity in human diabetes.
    Papadopoulos G; Lernmark A
    Behring Inst Mitt; 1984 Jul; (75):50-7. PubMed ID: 6435595
    [No Abstract]   [Full Text] [Related]  

  • 6. The immune response in individuals with HLA-DR specificities conferring susceptibility to insulin-dependent diabetes--a hypothesis.
    Papadopoulos G; Lernmark A
    Diabetes Res; 1984 May; 1(1):3-11. PubMed ID: 6085044
    [No Abstract]   [Full Text] [Related]  

  • 7. Events leading to insulin-dependent diabetes.
    Leslie RD; Lazarus NR; Vergani D
    Clin Sci (Lond); 1989 Feb; 76(2):119-24. PubMed ID: 2647362
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathogenesis of insulin-dependent (type I) diabetes mellitus].
    Weber B
    Monatsschr Kinderheilkd; 1985 Jun; 133(6):355-63. PubMed ID: 2931586
    [No Abstract]   [Full Text] [Related]  

  • 9. Proposed guidelines on screening for risk of type 1 diabetes.
    Bingley PJ; Bonifacio E; Ziegler AG; Schatz DA; Atkinson MA; Eisenbarth GS;
    Diabetes Care; 2001 Feb; 24(2):398. PubMed ID: 11213898
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunopathology of insulin-dependent diabetes. New hypothesis].
    Serrano Rodríguez S; Pujol-Borrell R; Bottazzo GF
    Rev Clin Esp; 1986 Apr; 178(6):299-307. PubMed ID: 3523648
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults.
    Kobayashi T; Tanaka S; Harii N; Aida K; Shimura H; Ohmori M; Kanesige M; Shimada A; Maruyama T
    Ann N Y Acad Sci; 2006 Oct; 1079():60-6. PubMed ID: 17130533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunogenetic mechanisms in the pathogenesis of type 1 diabetes mellitus].
    Tatoń J; Czech A; Podgórski G
    Pol Tyg Lek; 1984 Aug; 39(34):1141-6. PubMed ID: 6390380
    [No Abstract]   [Full Text] [Related]  

  • 13. Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus.
    Wilkin T; Hoskins PJ; Armitage M; Rodier M; Casey C; Diaz JL; Pyke DA; Leslie RD
    Lancet; 1985 Mar; 1(8427):480-1. PubMed ID: 2857852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism and genetic control of the autoimmune response directed against beta-pancreatic cells in insulin-dependent diabetes].
    Michelsen B; Baekkeskov S; Deufel T; Kastern W; Kofod H; Lernmark A; Vissing H
    Journ Annu Diabetol Hotel Dieu; 1985; ():171-82. PubMed ID: 2577960
    [No Abstract]   [Full Text] [Related]  

  • 15. New concepts of the etiopathogenesis and treatment of insulin-dependent diabetes mellitus.
    Bach JF
    Clin Rev Allergy Immunol; 2000 Dec; 19(3):217-25. PubMed ID: 11138406
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspartate at position 57 of nonobese diabetic I-Ag7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus.
    Quartey-Papafio R; Lund T; Chandler P; Picard J; Ozegbe P; Day S; Hutchings PR; O'Reilly L; Kioussis D; Simpson E
    J Immunol; 1995 May; 154(10):5567-75. PubMed ID: 7730655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-tolerance and differential susceptibility to diabetes in transgenic mice expressing major histocompatibility class II genes on pancreatic beta cells.
    Götz J; Eibel H; Köhler G
    Eur J Immunol; 1990 Aug; 20(8):1677-83. PubMed ID: 2209682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic issues in type 1 diabetes.
    Bloomgarden ZT
    Diabetes Care; 2001 Dec; 24(12):2143-9. PubMed ID: 11723097
    [No Abstract]   [Full Text] [Related]  

  • 20. Children at high risk of diabetes mellitus: New York studies of families with diabetes and of children with congenital rubella syndrome.
    McEvoy RC; Fedun B; Cooper LZ; Thomas NM; Rodriguez de Cordoba S; Rubinstein P; Ginsberg-Fellner F
    Adv Exp Med Biol; 1988; 246():221-7. PubMed ID: 3074654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.